ABIO Financial Statements (ABIO) |
|||||||
Артген биотех (ИСКЧ)smart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Report date | 27.03.2020 | 05.04.2021 | 04.04.2022 | 03.04.2023 | 01.04.2024 | ||
Currency | RUB | RUB | RUB | RUB | RUB | ||
Financial report URL | |||||||
Revenue, bln rub | ? | 0.069 | 0.060 | 0.081 | 0.081 | 0.074 | |
Net profit, bln rub | ? | 0.133 | 0.005 | 0.092 | 0.208 | 0.245 | |
Dividend payout, bln rub | 0.085 | 0.111 | |||||
Dividend, rub/share | ? | 1 | 1.2 | ||||
Ordinary share dividend yield, % | 0.0% | 0.0% | 0.0% | 1.6% | 1.2% | ||
Dividend payout ratio, % | 0% | 0% | 0% | 41% | 45% | ||
Cost of production, bln rub | 0.088 | 0.083 | 0.057 | 0.067 | 0.056 | ||
R&D, bln rub | 0.030 | ||||||
Assets, bln rub | 1.57 | 1.44 | 3.72 | 3.72 | 6.05 | ||
Net Assets, bln rub | ? | 0.860 | 0.710 | 2.57 | 3.07 | 5.45 | |
Debt, bln rub | 0.385 | 0.402 | 0.397 | 0.522 | 0.483 | ||
Cash, bln rub | 0.012 | 0.020 | 0.100 | 0.035 | 0.132 | ||
Net debt, bln rub | 0.37 | 0.38 | 0.30 | 0.49 | 0.35 | ||
Ordinary share price, rub | 13.0 | 38.2 | 115.0 | 62.1 | 102.0 | ||
Number of ordinary shares, mln | 75.0 | 75.0 | 85.0 | 92.6 | 92.6 | ||
Free Float, % | 15.0% | ||||||
Market cap, bln rub | 0.97 | 2.86 | 9.78 | 5.75 | 9.45 | ||
EV, bln rub | ? | 1.35 | 3.24 | 10.1 | 6.24 | 9.80 | |
Book value, bln rub | 0.86 | 0.71 | 2.57 | 3.07 | 5.45 | ||
EPS, rub | ? | 1.77 | 0.07 | 1.08 | 2.25 | 2.64 | |
FCF/share, rub | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
BV/share, rub | 11.5 | 9.47 | 30.2 | 33.1 | 58.8 | ||
EBITDA margin, % | ? | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
Net margin, % | ? | 192.8% | 8.3% | 114.0% | 258.1% | 331.1% | |
FCF yield, % | ? | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
ROE, % | ? | 15.5% | 0.7% | 3.6% | 6.8% | 4.5% | |
ROA, % | ? | 8.5% | 0.3% | 2.5% | 5.6% | 4.0% | |
P/E | ? | 7.33 | 572.4 | 106.3 | 27.6 | 38.6 | |
P/S | ? | 14.1 | 47.7 | 121.1 | 71.3 | 127.7 | |
P/BV | ? | 1.13 | 4.03 | 3.80 | 1.87 | 1.73 | |
CAPEX/Revenue, % | 0% | 0% | 0% | 0% | 0% | ||
ABIO shareholders |